抗EGFR 治疗在头颈部鳞癌中的研究进展.
伦立鑫， 钟振滨， 赵新宇， 吴筹… - Practical Oncology …, 2023 - search.ebscohost.com
… development of head and neck squamous cell carcinoma(… and treatment of HNSCC,including
cetuximab,nituzumab,afatinib,… 状细胞癌(Head and neck squamous cell carcinoma,HNSCC)…
cetuximab,nituzumab,afatinib,… 状细胞癌(Head and neck squamous cell carcinoma,HNSCC)…
抗EGFR 单抗治疗复发/转移性头颈部鳞状细胞癌临床共识(2021 年版)
郭晔， 张陈平 - 中国癌症杂志, 2021 - china-oncology.com
… [摘要] 头颈部鳞状细胞癌(squamous cell carcinoma of the head and neck,SCCHN)是头颈部
… Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell …
… Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell …
头颈鳞状细胞癌分子机制及免疫治疗进展
孙建梅， 胡冰心， 李妍， 宁云山 - 国际耳鼻咽喉头颈外科杂志, 2020 - entbjb.com
… miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck
squamous cell carcinoma cells by blocking JAK2-STAT3 signaling[J]. Biomed Pharmacother, …
squamous cell carcinoma cells by blocking JAK2-STAT3 signaling[J]. Biomed Pharmacother, …
[PDF][PDF] 程序性死亡受体-1 及其配体抑制剂在头颈部鳞状细胞癌免疫治疗的研究进展
曾飞， 卢洁， 孙仁浩， 房义康， 禹雯怡， 杨芳… - 口腔疾病防治, 2021 - scholar.archive.org
… receptor 1/ ligand 1 inhibitor in immunotherapy of head and neck squamous cell carcinoma
… Platinum⁃based chemo⁃ therapy plus cetuximab in head and neck cancer[J]. N Engl J Med…
… Platinum⁃based chemo⁃ therapy plus cetuximab in head and neck cancer[J]. N Engl J Med…
[HTML][HTML] 微型核糖核酸成為放射線治療的預後生物標記之研究
SY Lin - 2020 - ir.lib.ncu.edu.tw
… head and neck cancer cells. In this study, plasma samples were collected from patients of
head and neck cancer and colorectal cancer … radiosensitivity in head and neck cancer cells by …
head and neck cancer and colorectal cancer … radiosensitivity in head and neck cancer cells by …
[HTML][HTML] 尼妥珠单抗联合多西他赛和顺铂一线治疗复发或转移性头颈部鳞癌疗效观察
朱秋霞， 张振勇 - 肿瘤防治研究, 2021 - html.rhhz.net
… or metastatic head and neck squamous cell carcinoma patients… metastatic head and neck
squamous cell carcinoma patients … or metastatic head and neck squamous cell carcinoma, and …
squamous cell carcinoma patients … or metastatic head and neck squamous cell carcinoma, and …
TGFBI 在头颈部鳞状细胞癌中的表达及其临床意义
周一静， 邹建银， 易红良… - 山东大学耳鼻喉眼 …, 2023 - ebhyxbwk.njournal.sdu.edu.cn
… Expression of TGFBI in head and neck squamous cell carcinoma and its clinical significance[J].
Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 85-…
Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 85-…
[PDF][PDF] Ⅱ 型糖尿病: 不再是噩梦
DW Sharp - 科学观察, 2008 - manu56.magtech.com.cn
… 3 JA Bonner等, 放疗联合西妥昔单抗治疗头颈部鳞癌(Radiotherapy plus cetuximab for
squamous-cell carcinoma of the head and neck), New Engl. J. Med., 354(6): 567-78, 9 February …
squamous-cell carcinoma of the head and neck), New Engl. J. Med., 354(6): 567-78, 9 February …
抗EGFR 单抗治疗局部晚期头颈部鳞状细胞癌临床共识(2023 年版)
许婷婷， 胡超苏， 李宝生 - 中国癌症杂志, 2023 - china-oncology.com
… Head Neck, 2022, 44(3): 749-759. … The KRASvariant and cetuximab response in head and
neck squamous cell cancer: a secondary analysis of a randomized clinical trial[J]. JAMA Oncol…
neck squamous cell cancer: a secondary analysis of a randomized clinical trial[J]. JAMA Oncol…